MONTELUKAST 10 mg Tablets

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(36)

Andrei Popov

General medicinePain medicine7 years of experience

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use Montelukast Aurovitas

Contents of the leaflet

  1. Leaflet attached to the packaging: information for the user
  2. Montelukast Aurovitas, 10 mg, film-coated tablets
    1. You should read the contents of the leaflet before taking the medicine, as it contains important information for the patient.
    2. Table of contents of the leaflet:
  3. What is Montelukast Aurovitas and what is it used for
    1. What is Montelukast Aurovitas
    2. How Montelukast Aurovitas works
    3. When to use Montelukast Aurovitas
    4. What is asthma?
    5. What is seasonal allergy?
  4. Important information before taking Montelukast Aurovitas
    1. When not to take Montelukast Aurovitas:
    2. Warnings and precautions
    3. Various neuropsychiatric events (such as changes in behavior and mood, depression, and suicidal tendencies) have been reported in patients of all ages treated with montelukast (see section 4). If you experience such symptoms while taking
    4. Use in children and adolescents
    5. Other medicines and Montelukast Aurovitas
    6. Montelukast Aurovitas with food and drink
    7. Pregnancy and breastfeeding
    8. Driving and using machines
    9. Montelukast Aurovitas contains lactose
    10. Montelukast Aurovitas contains sodium
  5. How to take Montelukast Aurovitas
    1. Use in children and adolescents aged 15 and older
    2. Taking a higher dose of Montelukast Aurovitas than recommended
    3. Missing a dose of Montelukast Aurovitas
    4. Stopping treatment with Montelukast Aurovitas
  6. Possible side effects
    1. Severe side effects
    2. Other side effects reported after the medicine was placed on the market
    3. Reporting side effects
  7. How to store Montelukast Aurovitas
  8. Contents of the pack and other information
    1. What Montelukast Aurovitas contains
    2. What Montelukast Aurovitas looks like and contents of the pack
    3. Marketing authorization holder
    4. Manufacturer
    5. This medicinal product is authorized in the Member States of the European Economic Area under the following names:
    6. Date of last revision of the leaflet: 02.2024

Leaflet attached to the packaging: information for the user

Montelukast Aurovitas, 10 mg, film-coated tablets

Montelukast

You should read the contents of the leaflet before taking the medicine, as it contains important information for the patient.

  • You should keep this leaflet, so that you can read it again if you need to.
  • You should consult a doctor or pharmacist or nurse if you have any further doubts.
  • This medicine has been prescribed specifically for you. Do not pass it on to others.
  • The medicine may harm another person, even if their symptoms are the same.
  • If any of the side effects get worse or if you notice any side effects not listed in the leaflet, you should tell your doctor or pharmacist. See section 4.

Table of contents of the leaflet:

  • 1. What is Montelukast Aurovitas and what is it used for
  • 2. Important information before taking Montelukast Aurovitas
  • 3. How to take Montelukast Aurovitas
  • 4. Possible side effects
  • 5. How to store Montelukast Aurovitas
  • 6. Contents of the pack and other information
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

1. What is Montelukast Aurovitas and what is it used for

What is Montelukast Aurovitas

Montelukast Aurovitas is a leukotriene receptor antagonist, which blocks the action of substances called leukotrienes.

How Montelukast Aurovitas works

Leukotrienes cause the airways to narrow and swell, and cause allergy symptoms. By blocking the action of leukotrienes, Montelukast Aurovitas relieves the symptoms of asthma, makes it easier to control symptoms, and relieves the symptoms of seasonal allergies (also known as hay fever or seasonal allergic rhinitis).

When to use Montelukast Aurovitas

Your doctor has prescribed Montelukast Aurovitas to treat asthma and prevent its symptoms that occur during the day and at night.
Montelukast Aurovitas is used to treat children and adolescents aged 15 and older who have not achieved adequate control of asthma with the medications they are currently taking and need to take additional medications.
Montelukast Aurovitas also helps prevent narrowing of the airways caused by physical exertion.
In patients with asthma, for whom Montelukast Aurovitas is indicated due to asthma, it may also relieve the symptoms of seasonal allergic rhinitis.
Your doctor will determine how to use Montelukast Aurovitas based on the symptoms and severity of asthma that you have.

What is asthma?

Asthma is a chronic disease.
In asthma, there are:
breathing difficulties caused by narrowing of the airways. This narrowing worsens or improves in response to various factors.
sensitivity of the airways, which makes them react to many factors, such as: cigarette smoke, plant pollen, cold air, or physical exertion.
swelling (inflammation) of the lining of the airways.
The symptoms of asthma include: coughing, wheezing, and chest tightness.

What is seasonal allergy?

Seasonal allergy (also known as hay fever or seasonal allergic rhinitis) is an allergic reaction, often caused by airborne pollen from trees, grasses, and weeds. Typical symptoms of seasonal allergy may include: feeling of nasal congestion, runny nose, itching of the nose, sneezing, tearing, swelling, redness, itching of the eyes.

2. Important information before taking Montelukast Aurovitas

You should inform your doctor about all diseases or allergies that you have now or have had in the past.

When not to take Montelukast Aurovitas:

Warnings and precautions

Before starting to take Montelukast Aurovitas, you should discuss it with your doctor or pharmacist.

  • You should immediately inform your doctor if your asthma worsens or if you have difficulty breathing.
  • Montelukast Aurovitas taken orally is not intended for the treatment of acute asthma attacks. In case of an asthma attack, you should follow your doctor's instructions. You should always carry a rescue inhaler with you in case of an asthma attack.
  • It is important that you take all asthma medications prescribed by your doctor. You should not use Montelukast Aurovitas instead of other asthma medications prescribed by your doctor.
  • You should consult your doctor if you are taking asthma medications and experience symptoms such as: flu-like symptoms, tingling or numbness of the hands or feet, worsening of respiratory symptoms, and (or) rash.
  • You should not take aspirin or anti-inflammatory drugs (so-called non-steroidal anti-inflammatory drugs or NSAIDs) if they worsen your asthma symptoms.

Various neuropsychiatric events (such as changes in behavior and mood, depression, and suicidal tendencies) have been reported in patients of all ages treated with montelukast (see section 4). If you experience such symptoms while taking

montelukast, you should consult your doctor.

Use in children and adolescents

Do not give this medicine to children under 15 years of age.
There are different forms of the medicine available for pediatric patients under 18 years of age, depending on age.

Other medicines and Montelukast Aurovitas

You should tell your doctor or pharmacist about all medicines you are taking now or have taken recently, as well as about medicines you plan to take.
Some medicines may affect the action of Montelukast Aurovitas, or Montelukast Aurovitas may affect the action of other medicines.
Before starting to take Montelukast Aurovitas, you should tell your doctor about taking the following medicines:

  • phenobarbital (used to treat epilepsy),
  • phenytoin (used to treat epilepsy),
  • rifampicin (used to treat tuberculosis and some other infections),
  • gemfibrozil (used to treat high lipid levels in the blood).

Montelukast Aurovitas with food and drink

Montelukast Aurovitas 10 mg can be taken with or without food.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, or think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Your doctor will decide whether you can take Montelukast Aurovitas during this period.
Breastfeeding
It is not known whether Montelukast Aurovitas passes into breast milk. If you are breastfeeding or plan to breastfeed, you should consult your doctor before taking Montelukast Aurovitas.

Driving and using machines

You should not expect Montelukast Aurovitas to affect your ability to drive or use machines. However, individual reactions to the medicine may vary. Some side effects (such as dizziness and drowsiness) that have been reported with Montelukast Aurovitas may affect some people's ability to drive or use machines.

Montelukast Aurovitas contains lactose

Montelukast Aurovitas 10 mg film-coated tablets contain lactose. If you have intolerance to some sugars, you should contact your doctor before taking the medicine.

Montelukast Aurovitas contains sodium

This medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means that it is essentially 'sodium-free'.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to take Montelukast Aurovitas

This medicine should always be taken exactly as described in the patient information leaflet or as directed by your doctor or pharmacist or nurse. If you are unsure, you should consult your doctor or pharmacist or nurse.

  • You should take only one tablet of Montelukast Aurovitas once a day, as directed by your doctor.
  • You should take the medicine even if you do not have symptoms or if you have an acute asthma attack.

Use in children and adolescents aged 15 and older

The recommended dose is one 10 mg tablet once daily, in the evening.
If you are taking Montelukast Aurovitas, you should make sure that you are not taking other medicines that contain the same active substance, montelukast.
The medicine should be taken orally.
Montelukast Aurovitas 10 mg can be taken with or without food.

You should consult your doctor immediately.
In most cases of overdose, no side effects have been observed. The most common side effects reported after overdose of Montelukast Aurovitas in adults and children were: abdominal pain, drowsiness, increased thirst, headache, vomiting, and increased activity.

Missing a dose of Montelukast Aurovitas

You should try to take Montelukast Aurovitas as directed. If you miss a dose, you should go back to your usual schedule of taking one tablet once a day.
You should not take a double dose to make up for a missed dose.

Stopping treatment with Montelukast Aurovitas

Montelukast Aurovitas is effective in treating asthma only if it is taken regularly. It is important to continue taking Montelukast Aurovitas for as long as your doctor has prescribed it. This will help control your asthma.
If you have any further doubts about taking this medicine, you should consult your doctor or pharmacist or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
In clinical studies with montelukast 10 mg film-coated tablets, the most common side effects (which may affect up to 1 in 10 people but less than 1 in 100 people) that were probably related to montelukast were:

  • abdominal pain,
  • headache.

These symptoms were usually mild and occurred more often in patients treated with montelukast than in patients who received a placebo (a tablet that does not contain the medicine).

Severe side effects

You should contact your doctor immediatelyif you experience any of the following side effects, which may be severe and may require immediate medical attention.
Uncommon: may affect up to 1 in 100 people

  • allergic reactions, including swelling of the face, lips, tongue, and (or) throat, which may cause difficulty in breathing or swallowing
  • changes in behavior and mood: agitation, including aggressive behavior or hostility, depression
  • seizures

Rare: may affect up to 1 in 1,000 people

  • increased tendency to bleeding
  • tremor
  • palpitations

Very rare: may affect up to 1 in 10,000 people

  • a syndrome of symptoms such as flu-like symptoms, tingling or numbness of the hands and feet, worsening of respiratory symptoms, and (or) rash (Churg-Strauss syndrome) (see section 2)
  • low platelet count
  • changes in behavior and mood: hallucinations, disorientation, suicidal thoughts and attempts
  • inflammation (inflammation) of the lungs
  • severe skin reactions (erythema multiforme), which may occur without prior symptoms
  • liver inflammation

Other side effects reported after the medicine was placed on the market

Very common: may affect more than 1 in 10 people

  • upper respiratory tract infections

Common: may affect up to 1 in 10 people

  • diarrhea, nausea, vomiting
  • rash
  • fever
  • increased liver enzyme levels

Uncommon: may affect up to 1 in 100 people

  • changes in behavior and mood: unusual dreams, including nightmares, difficulty sleeping, sleepwalking, irritability, feeling anxious, restlessness
  • dizziness, drowsiness, tingling or numbness
  • nosebleeds
  • dry mouth, indigestion
  • bruising, itching, hives
  • muscle or joint pain, muscle cramps
  • bedwetting in children
  • weakness and (or) fatigue, malaise, swelling

Rare: may affect up to 1 in 1,000 people

  • changes in behavior and mood: attention disorders, memory disorders, uncontrolled movements

Very rare: may affect up to 1 in 10,000 people

  • tender, red lumps under the skin, most often on the shins (erythema nodosum)
  • changes in behavior and mood: obsessive-compulsive symptoms, stuttering

Reporting side effects

If you experience any side effects, including those not listed in the leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,
Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: + 48 22 49 21 301, fax: + 48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Montelukast Aurovitas

The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after the EXP date.
The expiry date refers to the last day of that month.
Do not store above 25°C.
Store in the original package to protect from light and moisture.
Use within 30 days of opening the HDPE bottle.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the pack and other information

What Montelukast Aurovitas contains

  • The active substance of the medicine is montelukast. One film-coated tablet contains montelukast sodium, which corresponds to 10 mg of montelukast.
  • The medicine also contains Core:lactose monohydrate, microcrystalline cellulose (E460), sodium carboxymethylcellulose, hydroxypropylcellulose (E463), magnesium stearate (E572).

Coating:hydroxypropylcellulose (E463), hypromellose 6cP (E464), titanium dioxide (E171), yellow iron oxide (E172), carnauba wax (E903), red iron oxide (E172).

What Montelukast Aurovitas looks like and contents of the pack

Film-coated tablets
Beige, square film-coated tablets with rounded edges, with the symbol "X" embossed on one side and "54" on the other.
Blister pack of polyamide/Aluminum/PVC/Aluminum in a cardboard box.
Pack sizes: 7, 10, 14, 20, 28, 30, 49, 50, 56, 60, 84, 90, 98, 100, 140, and 200 tablets
HDPE bottles with PP closure and desiccant in a cardboard box:
Pack sizes: 30 tablets
Not all pack sizes may be marketed.

Marketing authorization holder

Aurovitas Pharma Polska Sp. z o.o.
ul. Sokratesa 13D lokal 27
01-909 Warsaw

Manufacturer

APL Swift Services (Malta) Limited
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

France
Montelukast Arrow Lab 10 mg, film-coated tablet
Germany
Montelukast Aurobindo 10 mg film-coated tablets
Ireland
MONTELUKAST 10 mg Film-Coated Tablets
Italy
Montelukast Aurobindo 10mg film-coated tablets
Malta
Montelukast Aurobindo 10mg film-coated tablets
Netherlands
Montelukast Aurobindo 10 mg, film-coated tablets
Poland
Montelukast Aurovitas
Spain
Montelukast Aurovitas 10 mg film-coated tablets EFG

Date of last revision of the leaflet: 02.2024

Online doctors for Montelukast Aurovitas

Discuss questions about Montelukast Aurovitas, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

Doctor
5.0(36)

Andrei Popov

General medicinePain medicine7 years of experience

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Book a video appointment
€86
Doctor
5.0(12)

Yevgen Yakovenko

Family medicine12 years of experience

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Book a video appointment
€72
Doctor
5.0(3)

Lina Travkina

Family medicine13 years of experience

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Book a video appointment
€75
Doctor
5.0(2)

Dmytro Horobets

Family medicineEndocrinology7 years of experience

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Book a video appointment
€71
Doctor
5.0(19)

Nuno Tavares Lopes

Family medicineGeneral medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70

Get Montelukast Aurovitas Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for Montelukast Aurovitas?

Montelukast Aurovitas requires a prescription in Poland. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in Montelukast Aurovitas?

The active ingredient in Montelukast Aurovitas is montelukast. This information helps identify medicines with the same composition but different brand names.

Who manufactures Montelukast Aurovitas?

Montelukast Aurovitas is manufactured by APL Swift Services (Malta) Ltd.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of Montelukast Aurovitas online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether Montelukast Aurovitas is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy Montelukast Aurovitas in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy Montelukast Aurovitas in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to Montelukast Aurovitas?

Other medicines with the same active substance (montelukast) include Asmenol Pph, Asmenol Pph, Asmenol. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media